Abstract
Many strains of E. coli elaborate a hemolysin which is responsible for the zone of β-hemolysis surrounding bacterial colonies on blood agar. The significance of this cytolysin as a determinant of bacterial pathogenicity has been established in animal models with the use of genetically engineered, isogenic bacterial strains. An analogous role in human infections has been inferred from the high association of hemolysin production with disease. Studies at a molecular genetical level have defined 4 genes that are required for the synthesis, post,translational modification and secretion of the hemolysin. The structural gene hlyA encodes for a 107-110 000 polypeptide, which must be modified in an unknown manner to its active form by the product of the neighboring hlyC gene. Genes hlyb and hlyD encode for proteins that export the molecule to the extracellular medium. The signal for secretion is contained in the C-terminal portion of the toxin molecule. The secreted hemolysin attacks plasma membranes of target mammalian cells by inserting as a monomer into the bilayer and generating hydrophilic transmembrane pores of approximately 2 nm effective diameter. The pores display a marked selectivity for cations over anions and pore-opening is dependent on the presence of a correct transmembrane potential. Binding to a membrane target does not require the presence of a specific receptor, and pores may be generated in planar lipid membranes consisting solely of phosphatidylcholine. Pore formation in nucleated cells can trigger secondary reactions such as stimulation of arachidonate metabolism with release of lipid mediators, probably initiated by passive influx of extracellular Ca2+. Perfusion of subcytolytic doses through isolated and ventilated rabbit lungs induces lung edema that is at least partially due to such secondary events. The capacity of E. coli hemolysin to damage human tissues via primary and secondary processes is consistent with the concept of its pathogenic role in human infections.[/p]
Similar content being viewed by others
References
AmesG.F.L. (1986): The basis of multidrug resistance in mammalian cells: homology with bacterial transport. - Cell, 47: 323–324.
BergerH., HackerJ., JuarezA., HughesC. and GoebelW. (1982): Cloning of the chromosomal determinants encoding hemolysin production and mannose-resistant hemagglutination in Escherichia coli. - J. Bacteriol., 152: 1241–1247.
BhakdiS. and Tranum-JensenJ. (1978): Molecular nature of the complement lesion. - Proc. Natn. Acad. Sci. USA, 75: 5655–5659.
BhakdiS. and Tranum-JensenJ. (1987): Damage to mammalian cells by proteins that form transmembrane pores. - Rev. Physiol. Biochem. Pharmacol., 107: 148–223.
BhakdiS., Tranum-JensenJ. and SziegoleitA. (1985): Mechanism of membrane damage by streptolysin-O. -Infect. Immun., 47: 52–60.
BhakdiS., MackmanN., NicaudJ.M. and HollandI.B. (1986): E. coli hemolysin may damage target cell membranes by generating transmembrane pores. - Infect. Immun., 52: 63–69.
BohachG.A. and SnyderI.S. (1985): Chemical and immunological analysis of the complex structure of E. coli hemolysin. - J. Bacteriol., 164: 1071–1080.
BrooksH.J.L., O GradyF., McSherryM.A. and CattellW.R. (1980): Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection. -J. Med. Microbiol., 13: 57–68.
CavalieriS.J. and SnyderI.S. (1982): Cytotoxic activity of partially purified Escherichia coli alpha haemolysin. - J. Med. Microbiol., 15: 11–21.
CavalieriS.J. and SnyderI.S. (1982): Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro. - Infect. Immun., 36: 455–461.
CavalieriS.J. and SnyderI.S. (1982): Effect of Escherichia coli alpha-hemolysin peripheral leukocyte function in vitro. - Infect. Immun., 37: 966–974.
CavalieriS.J., BohachG.A. and SnyderI.S. (1984): Escherichia coli ξ-hemolysin: characteristics and probable role in pathogenicity. - Microbiol. Rev., 48: 326–343.
CookeE.M. and EwinsS.P. (1975): Properties of strains of Escherichia coli isolated from a variety of sources. - J. Med. Microbiol., 8: 107–111.
CramerW.A., OankertJ.R. and UrataniY. (1983): The membrane channel-forming bactericidal protein, colicin El. - Biochim. Biophys. Acta, 737: 173–193.
DeBoyJ.M., WachsmuthI.K. and DavisB.R. (1980): Hemolytic activity in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli. -J. Clin. Microbiol., 12: 836–840.
De laCruzF., ZabalaJ.C. and OrtizJ.M. (1983): Hemolysis determinant common to Escherichia coli strains of different O serotypes and origins. -Infect. Immun., 41: 881–887.
EvansD.J.Jr., EvansD.G., HohneC., NobleM.A., HaldaneE.V., LiorH. and YoungL.S. (1981): Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. - J. Clin. Microbiol., 13: 171–178.
FelmleeT., PelletS. and WelchR. (1985): Nucleotide sequence of an Escherichia coli chromosomal hemolysin. - J. Bacteriol., 163: 94–105.
FelmleeT., PelletS., LeeE.Y. and WelchR. (1985): Escherichia coli hemolysin is released extracellularly without cleavage of a signal peptide. - J. Bacteriol., 163: 88–93.
FriedF.A. and WongR.J. (1970): Etiology of pyelonephritis: significance of hemolytic Escherichia coli. - J. Urol., 103: 718–721.
FriedF.A., VermeulenC.W., GinsburgM.J. and ConeC.M. (1971): Etiology of pyelonephritis: further evidence associating the production of experimental pyelonephritis with hemolysis in Escherichia coli. - J. Urol., 106: 351–354.
FryT.L., FriedF.A. and GovenB.A. (1975): Pathogenesis of pyelonepbritis: Escherichia coli-induced renal ultrastructural changes. - Invest. Urol., 13: 47–51.
FüssleR., BhakdiS., SziegoleitA., Tranum-JensenJ., KranzT. and WellensiekH.J. (1981): On the mechanism of membrane damage by S. aureus α-toxin. - J. Cell Biol., 91: 83–94.
GadebergO.V. and OrskovI. (1984): In vitro cytotoxic effect of α-hemolytic Escherichia coli on human blood granulocytes. - Infect. Immun., 45: 255–260.
GadebergO.V., OrskovI. and RhodesJ.M. (1983): Cytotoxic effect of an alpha-hemolytic Escherichia coli strain on human blood monocytes and granulocytes in vitro, - Infect. Immun., 41: 358–364.
GerlachJ.H., EndicottJ.A., JurankaP.F., HendersonG., SarangiF., DeucharsK.L. and LingV. (1986): Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. - Nature, 324: 485–489.
GoebelW. and HedgepethJ. (1982): Cloning and functional characterization of the plasmid-encoded hemolysin determinant of Escherichia coli. - J. Bacteriol., 151: 1209–1298.
GoebelW., Royer-PokoraB., LindenmaierW. and BujardH. (1974): Plasmids controlling synthesis of hemolysin in Escherichia coli: molecular properties. -J. Bacteriol., 118: 964–973.
Gonzalez-CarreroM.I., ZabalaJ.C., CruzF.de la and OritzJ.M. (1985): Purification of α-haemolysin from an overproducing E. coli strain. - Mol. Gen. Genet., 199: 106–110.
GrayL., MackmanN., NicaudJ.M. and HollandI.B. (1986): The carboxy-terminal region of haemolysin 2001 is required for secretion of the toxin from Escherichia coli. - Mol. Gen. Genet., 205: 127–133.
GreenC.P. and ThomasV.L. (1981): Hemagglutination of human type O erythrocytes, hemolysin production, and serogrouping of Escherichia coli isolates from patients with acute pyelonephritis, cystitis, and asymptomatic bacteriuria. - Infect. Immun., 31: 309–315.
HackerJ., HughesC., HofH. and GoebelW. (1983): Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice. - Infect. Immun., 52: 57–63.
HackerJ., KnappS. and GoebelW. (1983): Spontaneous deletions and flanking regions of the chromosomally inherited hemolysin determinant of an Escherichia coli 06 strain. - J. Bacteriol., 154: 1145–1152.
HenkartP. (1985): Mechanism of lymphocyte-mediated cytotoxicity. - A. Rev. Immunol., 3: 31–58.
HigginsC.F., HilesI.D., SalmondG.P.C.; GillD.R., DownieJ.A., EvansI.J., HollandI.B., GrayL., BuckelS.D., BellA.W. and HermodsonM.A. (1986): A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. -Nature, 323: 448–450.
HughesC., HackerJ., RobertsA. and GoebelW. (1983): Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli. - Infect. Immun., 39: 546–551.
HughesC., PhillipsR. and RobertsA.P. (1982): Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin and antibiotic resistance determinants. - Infect. Immun., 35: 270–275.
HugoF., ArvandM., ReichweinJ., MackmanN., HollandI.B. and BhakdiS. (1987): Identification of hemolysin produced by clinical isolates of E. coli with monoclonal antibodies. - J. Clin. Microbiol., 25: 26–30.
HullS.I., HullR.A., MinshewB.H. and FalkowS. (1982): Genetics of hemolysin of Escherichia coli. -J. Bacteriol., 151: 1006–1012.
JorgensenS.E., HammerR.F. and WuG.K. (1980): Effects of a single hit from alpha-hemolysin produced by Escherichia coli on the morphology of sheep erythrocytes. - Infect. Immun., 27: 988–994.
JorgensenS.E., MulcahyP.F., WuG.K. and LouisC.F. (1983): Calcium accumulation in human and sheep erythrocytes that is induced by Escherichia coli hemolysin. - Toxicon, 27: 717–727.
KönigB., KönigW., SchefferJ., HackerJ. and GoebelW. (1986): Role of Escherichia coli hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. - Infect. Immun., 54: 886–892.
LebekG. and GruenigH.M. (1985): Relation between the hemolytic property and iron metabolism in Escherichia coli. - Infect. Immun., 50: 682–686.
LinggoodM.A. and IngramP.L. (1982): The role of alpha haemolysin in the virulence of Escherichia coli for mice. - J. Med. Microbiol., 15: 23–30.
LudwigA., VogelM. and GoebelW. (1987): Mutations affecting activity and transport of haemolysin in Escherichia coli. - Mol. Gen. Genet., 206: 238–245.
MackmanN. and HollandI.B. (1984): Secretion of a 107K dalton polypeptide into the medium from a haemolytic E. coli K12 strain. - Mol. Gen. Genet., 193: 312–315.
MackmanN. and HollandI.B. (1984): Functional characterization of a cloned haemolysin determinant from E. coli of human origin, encoding information for the secretion of a 107K polypeptide. -Mol. Gen. Genet., 196: 123–134.
Mackman N., Baker K., Gray L., Haigh R., Nicaud J.M. and Holland I.B. (1987) : Release of a chimeric protein into the medium from E. coli. - EMBO in press.
MackmanN., NicaudJ.M., GrayL. and HollandI.B. (1985): Genetical and functional organisation of the Escherichia coli haemolysin determinant 2001. - Mol. Gen. Genet., 201: 282–288.
MackmanN., NicaudJ.M., GrayL. and HollandI.B. (1985): Identification of polypeptides required for the export of haemolysin 2001 from E. coli. -Mol. Gen. Genet., 201: 529–536.
MackmanN., NicaudJ.M., GrayL. and HollandI.B. (1986): Secretion of hemolysin by E. coli. -Curr. Top. Microbiol. Immunol., 125: 159–181.
MenestrinaG., MackmanN., HollandI.B. and BhakdiS. (1987): E. coli hemolysin forms voltage-dependent ion channels in lipid membranes. - Biochim. Biophys. Acta, 105: 109–117.
MinshewB.H., JorgensenJ., CountsG.W. and Fal-kowS. (1978): Association of hemolysin production, hemagglutination of human erythrocytes, and virulence for chicken embryos of extraintestinal Escherichia coli isolates. - Infect. Immun., 20: 50–54.
MinshewB.H., JorgensenJ., SwansrutmM., Grootes-ReuvecampG.A. and FalkoivS. (1978): Some characteristics of Escherichia coli strains isolated from extraintestinal infections of humans. - J. Infect. Dis., 137: 648–654.
MullerD., HughesC. and GoebelW. (1983): Relationship between plasmid and chromosomal hemolysin determinants of Escherichia coli. - J. Bacteriol., 153: 846–851.
NicaudJ.M., MackmanN., GrayL. and HollandI.B. (1985): Regulation of haemolysin synthesis in E. coli determined by Hly genes of human origin. - Mol. Gen. Genet., 199: 111–116.
NicaudJ.M., MackmanN., GrayL. and HollandI.B. (1986): The C-terminal, 23 kDa peptide of E. coli haemolysin 2001 contains all the information necessary for its secretion by the haemolysin (Hly) export machinery. - FEBS 204: 331–335.
RennieR.P. and ArbuthnottJ.P. (1974): Partial characterisation of Escherichia coli haemolysin. -J. Med. Microbiol., 7: 179–188.
RennieR.P., FreerJ.H. and ArbuthnottJ.P. (1974): The kinetics of erythrocyte lysis by Escherichia coli haemolysin. - J. Med. Microbiol., 7: 189–195.
ScheinS.J., KaganB.L. and FinkelsteinA. (1978): Colicin K acts by forming voltage-dependent channels in phospholipid bilayer membranes. - Nature, 276: 159–161.
Seeger W., Bauer M. and Bhakdi S. (1984): Staphylococcal α-toxin elicits hypertension in isolated rabbit lungs due to stimulation of the arachidonic acid cascade. - J. Clin. Invest., 74: 849–858.
Seeger W., SuttorpN., HellwigA. and BhakdiS. (1986): Non-cytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. - J. Immun., 137: 1286–1291.
ShortE.C.Jr. and KurtzH.J. (1971): Properties of the hemolytic activities of Escherichia coli. -Infect. Immun., 3: 678–687.
SmithH.W. and LinggoodM.A. (1971): Observations on the pathogenic properties of the K88, hly and ent plasmids of Escherichia coli with particular reference to porcine diarrhoea. - J. Med. Microbiol., 4: 467–485.
SnyderI.S. and ZwadykP. (1969): Some factors affecting production and assay of Escherichia coli haemolysins. - J. Gen. Microbiol., 55: 139–143.
SpringerW. and GoebelW. (1980): Synthesis and secretion of hemolysin by Escherichia coli. - J. Bacteriol., 144: 53–59.
Suttorp N., Seeger W., DeweinE., BhakdiS. and RokaL. (1985): Staphylococcal α-toxin stimulates synthesis of prostacyclin by cultured endothelial cells from pig pulmonary arteries. - Am. J. Physiol., 248: C127-C135.
van denBoschJ.F., deGraaffJ. and MacLarenD.M. (1979): Virulence of Escherichia coli in experimental bematogenous pyelonephritis in mice. -Infect. Immun., 25: 68–74.
van denBoschJ.F., EmodyL. and KetyiI. (1982): Virulence of haemolytic strains of Escherichia coli in various animal models. - FEMS Microbiol. Lett., 13: 427–430.
van denBoschJ.F., PostmaP., deGraaffJ. and MacLarenD.M. (1981): Haemolysis by urinary Escherichia coli and virulence in mice. - J. Med. Microbiol., 14: 321–331.
van denBoschJ.F., PostmaP., KoopmanP.A.R., deGraaffJ., MacLarenD.M., vanBrenkD.G. and GuineeP.A.M. (1982): Virulence of urinary and faecal Escherichia coli in relation to serotype, haemolysis and haemagglutination. - J. Hyg., 88: 567–57.
WaalwijkC. and de GraaffJ, (1983): Inactivation of haemolysin production in Escherichia coli by transposon insertion results in loss of virulence. Antoine van Leeuwenhoek J. Microbiol. Serol., 42: 23–30.
WaalwijkC., MacLarenD.M. and deGraaffJ. (1983): In vivo function of hemolysin in the nephropathogenicity of Escherichia coli. - Infect. Immun., 42: 245–249.
WaalwijkC., van denBoschJ.F., MacLarenD.M. and deGraaffJ. (1982): Hemolysin plasmid coding for the virulence of a nephropathogenic Escherichia coli strain. - Infect. Immun., 35: 32–37.
WagnerW., VogelM. and GoebelW. (1983): Transport of hemolysin across the outer membrane of Escherichia coli requires two functions. - J. Bacteriol., 150: 200–210.
WelchR.A., DelllingerE.P., MinshewB. and FalkowS. (1981): Haemolysin contributes to virulence of extra-intestinal E. coli infections. - Nature (London), 294: 665–667.
WelchR.A. and FalkowS. (1984): Characterization of Escherichia coli hemolysins conferring quantitative differences in virulence. - Infect. Immun., 43: 156–160.
WelchR.A., HullR. and FalkowS. (1983): Molecular cloning and physical characterization of a chromosomal hemolysin from Escherichia coli. -Infect. Immun., 42: 178–186.
ZwadykP. and SnyderI.S. (1971): Purification and kinetic studies of the hemolysin from Escherichia coli. - Can. J. Microbiol., 17: 741–745.
Author information
Authors and Affiliations
Additional information
Corresponding author.
Rights and permissions
About this article
Cite this article
Bhakdi, S., Mackman, N., Menestrina, G. et al. The hemolysin of escherichia coli . Eur J Epidemiol 4, 135–143 (1988). https://doi.org/10.1007/BF00144740
Issue Date:
DOI: https://doi.org/10.1007/BF00144740